6th Annual Immune Checkpoint Inhibitors (ICI Europe 2020) is a conference that covers topics such as:
- How to deliver maximum clinical benefit through immune checkpoint monotherapy and combinations
- Preclinical, translational and clinical challenges in drug development while advancing more checkpoint inhibitors onto the market
- Novel checkpoint pathways
- What it takes to develop the next generation of ICI drugs, from pathway validation to clinical success
- The optimal combination strategies
- Predictive preclinical models
- Emerging clinical trial data
- Patient stratification biomarkers
6th Annual Immune Checkpoint Inhibitors (ICI Europe 2020) brings together senior attendees with job titles such as
- VP
- CEO
- Principal Scientist
- CSO
- VP Regulatory & Clinical Affairs
- Senior Director of Cancer Immunology
- Global Strategic Lead – Immunology
- Chief Development Officer
involved in:
- Immune Oncology
- Immuno-oncology
- Oncology
- Cancer Immunotherapy
- Clinical Oncology
- Discovery Oncology
- Immunology
- Cancer Biology
- Preclinical Oncology
- Cell Biology
- Business Development
- Translational Science